A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). - Wikidata - awgldk - TriplyDB

A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL).

A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL).

http://www.wikidata.org/entity/Q47776771

about

Interventions for chronic idiopathic urticaria excluding antihistamines Guideline of Chronic Urticaria Beyond Advances in Understanding and Managing Chronic Urticaria Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy Profile of omalizumab in the treatment of chronic spontaneous urticaria Management of urticaria: not too complicated, not too simple Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria.Insights and advances in chronic urticaria: a Canadian perspective.Impact of chronic urticaria on the quality of life in Australian and Sri Lankan populations.The impact of chronic urticaria on the quality of life in Indian patients.ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.A study of treatment adherence and quality of life among adults with chronic urticaria in Singapore.Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.EAACI/GA2LEN/EDF guideline: management of urticaria.Effect of the pruritus on the quality of life: a preliminary study.Sleep disturbances in allergic diseases.Assessing Changes in Chronic Spontaneous/Idiopathic Urticaria: Comparisons of Patient-Reported Outcomes Using Latent Growth Modeling.Occurrence of sleep-related breathing disorders in patients with chronic urticaria at its asymptomatic or oligosymptomatic stages.Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT)Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.Challenges in the management of chronic urticaria.Incidence of allergic contact sensitization in central Chinese subjects with chronic urticaria.Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies.State of the art of chronic spontaneous urticaria in Italy: a multicentre survey to evaluate physicians' and patients' perspectives.Impact of chronic urticaria on the quality of life of patients followed up at a university hospital.Chronic spontaneous urticaria in children: itching for insight.Systematic literature review and evaluation of patient reported outcome measures (PROMs) for asthma and related allergic diseases.The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment.An individualized diagnostic approach based on guidelines for chronic urticaria (CU).Urticaria Guidelines: Consensus and Controversies in the European and American Guidelines.Why a registry of Chronic Urticaria (CUR) is needed.The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis.Analysis of Disease Activity Categories in Chronic Spontaneous/Idiopathic Urticaria.Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.Patient-reported outcomes (PROs) in chronic urticaria.

P2860

Q24201342-E3C27931-6D52-477B-B825-45BB0093F7A7 Q26743369-262681DC-4B49-428F-81D2-B881A8B908FF Q26767461-A13BB1B1-C22B-463E-9FB4-69D4084AEE49 Q26777088-BFAE57EA-EF68-4FFE-95E2-C335E13C0564 Q26783158-D08A5DCF-5611-401B-B4A2-7AB10A3D7503 Q26828373-2631E542-AD05-4B28-B343-A59582851A16 Q34150295-ACF26CF8-C958-4E5F-A5DE-7E962FCA4815 Q34516254-CC094D23-CD7B-49F9-96FD-CE27B4E287FE Q34734113-92846700-2073-4527-BEE2-50EB5FF5F2F5 Q35108534-85BDF7E3-5AD8-477E-A8DF-B57CD2E58B2F Q35502374-2304BE9D-E92B-4712-98B2-C84E86B87EE7 Q35961540-A5235EFA-5D97-4BB2-B7D8-190E795E8C47 Q35961702-383CBC64-7B49-47AD-B75D-BAED8E4517B8 Q36241656-6D1463B9-B884-43C4-8D03-B1D2B381D118 Q36359983-5B68A812-6B00-4A2D-8754-40BC192FCC9E Q36377285-3226BAA8-C8A0-49FA-B35B-0C0791986E96 Q36421607-6ACB9AA6-FABE-48FE-8F1D-2631EF5230DB Q36604443-F6DF02EE-9D8D-43E6-8CC2-9BFDC01519F4 Q36626205-CC118650-8C42-4203-90C1-3EBA06D8B11D Q36690510-14A1DAB1-7952-42DC-914E-B8B0A86844B0 Q36759592-8E58D854-D810-4D6A-BE6F-81AA232E2021 Q36796880-0BD85698-D7F1-4313-BFE7-3E897FF8730F Q36834774-0A2E0178-ED25-4640-A614-A032A7D5FA17 Q36882652-A66E3C67-8B37-4A80-A2FC-A4BE9D0848C5 Q36885071-6250FA89-2712-4B58-921D-611DB1C5F97E Q37185706-9EB7B675-1EE6-43BB-86C6-B484F34FDFD7 Q37356236-386C9217-36B4-40DA-9616-978BA94F0272 Q37540414-A870593C-23FB-42DC-A05A-784C5D5772FE Q37831967-CFCBE8A2-16FE-4EC6-8D08-48CCBB94E731 Q38045730-27C117EA-3210-483B-AB77-C9AD9A3CBCD4 Q38208428-863248D7-D29A-4561-AA55-990B959B48F9 Q38428381-FF706E31-6EA8-4C25-B5CD-F0AC6A48469D Q38520215-81D133FD-9179-47A5-B73D-485E13494A5B Q38542586-1DD73120-C2DC-4364-AA0E-369459CBA244 Q38762661-1E177491-E035-4E01-8437-DE23B28B9BCB Q38764670-54D108F3-0AAC-4075-98F4-70FC10E2A3EF Q38847557-B49D83C6-66FC-4D93-B75D-8F7F75B0ED42 Q38907099-FC24895A-79BC-4835-B826-9306250B920A Q38997626-BB232C66-E400-4A87-A5C7-3051F8FD0243 Q39343082-A829A16D-14E2-4A5D-A721-618974982A00

P2860

A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL).

http://www.wikidata.org/entity/Q47776771

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

A new tool to evaluate the imp ...... f life questionnaire (CU-QoL).

@en

A new tool to evaluate the imp ...... quality of life questionnaire

@nl

type

label

A new tool to evaluate the imp ...... f life questionnaire (CU-QoL).

@en

A new tool to evaluate the imp ...... quality of life questionnaire

@nl

prefLabel

A new tool to evaluate the imp ...... f life questionnaire (CU-QoL).

@en

A new tool to evaluate the imp ...... quality of life questionnaire

@nl

P1433

Q47776771-4090EE4C-78CD-40F1-8D00-AE33DDA1EC12

P1476

Q47776771-C5D1358D-5E16-464D-9F39-6AC3F89F2187

P2093

Q47776771-60044A81-3201-4C70-9BAB-74BC2970E1A4

Q47776771-60F9BDB0-DFED-439D-B2C9-A258F134D249

Q47776771-6C3A2466-1ABB-45D5-AE11-E34F6E5A52F2

Q47776771-72754485-B72C-455C-A5C6-746950DA5537

Q47776771-96BDDE3B-DB1F-4E5D-8442-796239642EBF

Q47776771-ACFE481D-60EE-48D5-96CC-90F0F3E3B11A

Q47776771-BB1913B7-12CA-4BCB-AC14-630EAC3B91E9

Q47776771-C8EF4FBC-2704-4B98-9482-C4668D1888EC

Q47776771-D5ECCB26-FD28-47DF-B790-6E49EF138C52

P2860

Q47776771-0A2476C3-6E96-4AFC-99FA-879ECCD0E565

Q47776771-1B420394-11FA-4ACD-86EA-74AC34E230CB

Q47776771-3E2A2688-BA9E-40D3-B9A9-F5A956580C02

Q47776771-90943E39-5823-4311-A761-0B06FAAEBFAE

Q47776771-9A3302D9-DAB4-4D61-BD52-13DDA42B277B

Q47776771-9A99449A-6F1D-4D57-8241-B96DA87F0B96

Q47776771-9E978900-497C-4260-9A58-0F0407881150

Q47776771-C2AF79B0-3E61-4034-A2EA-BA13B77BAD0C

Q47776771-C4DB7C69-CF2D-465E-8AF2-09144C894B15

Q47776771-CCDE82B1-60BB-4A3C-87F0-D59E8A8A4D27

P304

Q47776771-3E90E91C-D5DE-426A-BE6A-58BA5F70F7AC

P31

Q47776771-50B6D6E7-47D8-4224-A1B0-105F63C30089

P356

Q47776771-1A0027AF-5121-425A-A11C-C8F887062024

P433

Q47776771-0CECDF02-856C-40C8-8874-FB3A3DFB04E0

P478

Q47776771-EBB0A285-5075-4D68-824C-245996A184B5

P50

Q47776771-D0E84A56-1AB3-4AAC-AFC7-6F732A4795C9

P577

Q47776771-DF61080B-DDD4-41DB-946E-C8102354B1F6

P5875

Q47776771-BCC9C4EA-9AE0-49B4-82EE-F91C90D27EF8

P698

Q47776771-EDAE7ABF-1209-432B-BC30-685318A20569

P921

Q47776771-5EE41C9D-8C6F-4F1A-AACC-701F6395B57D

Q47776771-C9BC3BDE-3C46-459A-8F80-C2380C4580EA

P356

J.1398-9995.2005.00833.X

P1433

P1476

A new tool to evaluate the imp ...... of life questionnaire (CU-QoL)

@en

P2093

Baiardini I

http://www.w3.org/2001/XMLSchema#string

Braga M

http://www.w3.org/2001/XMLSchema#string

Braido F

http://www.w3.org/2001/XMLSchema#string

Compalati E

http://www.w3.org/2001/XMLSchema#string

Fassio O

http://www.w3.org/2001/XMLSchema#string

Fumagalli F

http://www.w3.org/2001/XMLSchema#string

Guerra L

http://www.w3.org/2001/XMLSchema#string

Lombardi C

http://www.w3.org/2001/XMLSchema#string

Pasquali M

http://www.w3.org/2001/XMLSchema#string

P2860

The extent and nature of disability in different urticarial conditions

Health-related quality of life and hand eczema--a comparison of two instruments, including factor analysis.

Skin cancer and quality of life: assessment with the Dermatology Life Quality Index.

Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.

The unfavorable effects of concomitant asthma and sleeplessness due to the atopic eczema/dermatitis syndrome (AEDS) on quality of life in subjects allergic to house-dust mites.

The impact of chronic urticaria on the quality of life.

Development and validation of a health-related quality of life instrument for women with melasma.

Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy.

The burden of psoriasis is not determined by disease severity only.

Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1.

P304

1073-1078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1398-9995.2005.00833.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Giorgio Walter Canonica

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7773114

http://www.w3.org/2001/XMLSchema#string

P698

15969690

http://www.w3.org/2001/XMLSchema#string

P921

quality of life